COMMUNIQUÉS West-GlobeNewswire

Rad Source Technologies Announces Configurable Filters for the RS® 2000·Q2 Biological Irradiator
11/03/2026
BUFORD, Ga., March 11, 2026 (GLOBE NEWSWIRE) -- Rad Source Technologies (Rad Source ® ), a global leader in advanced X‑ray solutions for life sciences, today announced the launch of Configurable Filters for the RS ® [...]
Pliant Therapeutics Provides Corporate Update and Reports Fourth Quarter 2025 Financial Results
11/03/2026
PLN-101095 Phase 1 data showed deep and durable ongoing responses in checkpoint inhibitor refractory solid tumors PLN-101095 accelerated development plan underway with initiation of Phase 1b indication expansion trial [...]
Codexis Reports Fourth Quarter and Fiscal Year 2025 Financial Results
11/03/2026
Q4 revenue of $38.9 million, total revenue of $70.4 million for the fiscal year ended December 31, 2025 Ended year with $78.2 million in cash, cash equivalents and short-term investments, runway through 2027 Completed $ [...]
Elutia Reports Fourth Quarter and Full Year 2025 Financial Results; Initiates NXT-41 Regulatory Process
11/03/2026
– Base biologic matrix NXT-41 submitted to FDA; on track for anticipated FDA clearance in second half of 2026 and full NXT-41x clearance in 1H27 – – $44.4 million in cash and escrowed proceeds at year-end – – Conference [...]
RadNet, Inc. to Present at the 28th Annual Barclays Global Healthcare Conference on Thursday, March 12th
11/03/2026
LOS ANGELES, March 11, 2026 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT ), a national leader in providing high-quality, cost-effective diagnostic imaging services and digital health solutions, today announced that [...]
BioXcel Therapeutics Announces Closing of $8.0 Million Registered Direct Offering
11/03/2026
NEW HAVEN, Conn., March 11, 2026 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (the “Company”) (Nasdaq: BTAI), a biopharmaceutical company built on artificial intelligence to develop transformative medicines in [...]
Longeveron Announces Closing of Private Placement of up to $30 Million
11/03/2026
$15 million upfront with a milestone-driven potential additional $15 million related to the Company’s anticipated pivotal clinical trial in Hypoplastic Left Heart Syndrome (HLHS) priced at the market under Nasdaq rules [...]
BioStem Technologies to Host Fourth Quarter and Full Year 2025 Financial Results Conference Call on March 24, 2026
11/03/2026
Conference call and webcast to be held at 4:30 PM ET POMPANO BEACH, Fla., March 11, 2026 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC: BSEM), a leading MedTech company focused on the development, manufacturing, [...]
GUERBET : 2025 full-year results.
11/03/2026
2025 full-year results Revenue : €786.4 million, down 3.5% at CER 1 and like-for-like 2 , mainly due to the fall in activity in France Profitability : restated EBITDA margin 3 of 12.0% (at the high end of the adjusted [...]
Solid Biosciences Provides Interim Positive Clinical Update on Phase 1/2 INSPIRE DUCHENNE Trial
11/03/2026
- 40 participants have been dosed with SGT-003 in the INSPIRE DUCHENNE trial to date - - Robust microdystrophin expression with consistent mechanistic evidence of dystrophin associated protein complex (DAPC) restoration [...]
GUERBET : Résultats annuels 2025.
11/03/2026
Résultats annuels 2025 Chiffre d’affaires : 786,4 M€, soit un repli de 3,5% à TCC 1 et périmètre comparable 2 , dû essentiellement à la baisse de l’activité en France Rentabilité : la marge d’EBITDA retraité 3 ressort à [...]
GUERBET : Change in Guerbet’s Board of Directors.
11/03/2026
Change in Guerbet’s Board of Directors Villepinte, March 11th, 2026: Guerbet (FR0000032526 GBT), a global leader in contrast agents and solutions for medical imaging, today announced, at its Board of Directors’ meeting [...]
Human Appeal's #ForMama26 Campaign to Save only Maternity Hospital in Northwest Syria
11/03/2026
Partnership with Every Pregnancy aims to provide a critical lifeline for thousands of mothers and babies at Al Imaan Hospital through a matched funding campaign MISSION VIEJO, Calif., March 11, 2026 (GLOBE NEWSWIRE) -- [...]
GUERBET : Evolution du Conseil d’Administration de Guerbet.
11/03/2026
Evolution du Conseil d’Administration de Guerbet Villepinte, le 11 mars 2026 : Guerbet (FR0000032526 GBT), spécialiste mondial des produits de contraste et solutions pour l’imagerie médicale, annonce la nomination ce [...]
Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons
11/03/2026
Please see enclosed pdf. Attachment 11032026_trading_in_shares_JNA
BBP-418 Demonstrates Consistent Efficacy and Favorable Safety Profile in Phase 3 FORTIFY Interim Analysis in LGMD2I/R9
11/03/2026
- Phase 3 FORTIFY interim analysis results presented in a late-breaking oral presentation at MDA highlight the broad and consistent efficacy of BBP-418 across key clinical endpoints and prespecified subgroups - Early [...]
Cosmos Health Purchases $600,000 of Bitcoin, Expands Digital Asset Holdings to $3,100,000
11/03/2026
CHICAGO, March 11, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM) , a diversified, vertically integrated global healthcare group, today announced the purchase of $600,000 of [...]
Weight Watchers Report Finds Integrated GLP-1 Support Drives Significantly Greater Weight Loss Than Medication Alone
11/03/2026
Weight Watchers’ Med+ members who regularly engaged with their GLP-1 Success Program lost up to 61% more body weight in the first month and 29% more in one year, on average, than those who took medication alone. Med+ [...]
Trinity Biotech Senior Executives to Attend ATTD 2026 to Advance Collaborations Following Strong Progress in CGM Program
11/03/2026
- Company accelerating partner engagement ahead of pivotal clinical trial to be initiated in 2026 DUBLIN and WILSONVILLE, Ore., March 11, 2026 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage [...]

Pages